Our most influential papers

recent high impact publications

  • Ribosomal protein L24 mediates mammalian microRNA processing in an evolutionarily conserved manner.
    Tzur Y, Dubnov S, Madrer N, Bar A, Nadorp B, Mishra N, Heppenstall P, Bennett ER, Greenberg DS, Winek K, Soreq H
    Cell Mol Life Sci 2024, 81(1), 55
  • Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.
    Jessen* M, Gertzmann* D, Liss* F, Zenk F, Bähner L, Schöffler V, Schulte C, Maric HM, Ade CP, von Eyss** B, Gaubatz** S
    Oncogene 2024 (epub ahead of print) * equal contribution, ** co-corresponding authors
  • PAPAS promotes differentiation of mammary epithelial cells and suppresses breast carcinogenesis.
    Ren S, Bai F, Schnell V, Stanko C, Ritsch M, Schenk T, Barth E, Marz M, Wang B, Pei XH, Bierhoff H
    Cell Rep 2024 (epub ahead of print)
  • Remodelling of the cardiac extracellular matrix proteome during chronological and pathological ageing.
    Santinha D, Vilaça A, Estronca L, Schüler SC, Bartoli C, De Sandre-Giovannoli A, Figueiredo A, Quaas M, Pompe T, Ori** A, Ferreira** L
    Mol Cell Proteomics 2024, 23(1), 100706 ** co-corresponding authors
  • Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
    Tubío-Santamaría N, Jayavelu AK, Schnoeder TM, Eifert T, Hsu CJ, Perner F, Zhang Q, Wenge DV, Hansen FM, Kirkpatrick JM, Jyotsana N, Lane SW, von Eyss B, Deshpande AJ, Kühn MWM, Schwaller J, Cammann C, Seifert U, Ebstein F, Krüger E, Hochhaus A, Heuser M, Ori A, Mann M, Armstrong SA, Heidel FH
    Mol Cancer 2023, 22(1), 196
  • Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL.
    Antić Ž, van Bömmel A, Riege K, Lentes J, Schröder C, Alten J, Eckert C, Fuhrmann L, Steinemann D, Lenk L, Schewe DM, Zimmermann M, Schrappe M, Schlegelberger B, Cario G, Hoffmann S, Bergmann AK
    Leukemia 2023, 37(12), 2522-5